A Decade of Clarity: celebrating ten years of building, evolving, and investing.

A Decade of Clarity: celebrating ten years of building, evolving, and investing.

Search Results

MATT 2025 Recap: Nitazene Analogs

At this year’s MATT meeting, Stuart Kurtz spoke to attendees about the prevalence of nitazene analogs and the concentrations at which Axis detects them. We have previously discussed what nitazenes are in blog posts (see links below).  As a reminder, they are potent mu...

Drug Primer: Nitazenes

By Kevin Shanks, D-ABFT-FT Over the last several years, the Drug Enforcement Administration (DEA) has moved to ban various newly emerged illicit opioids as Schedule I controlled substances. From 2015-2017, they controlled 19 fentanyl analogs and other opioids. In...

Nitazene Analog Panel Coming Soon

Dear Valued Client, In the spirit of continual improvement, to provide the most relevant panels and tests in the industry, our products are periodically updated as new compounds emerge and older compounds cease to be relevant over the years. It is with that goal in...

Axis Experts Present at MATT 2025

Axis toxicologists Laureen Marinetti, PhD, F-ABFT, and Stuart Kurtz, M.S, D-ABFT-FT, will be presenting at the Midwest Association of Toxicology and Therapeutic Drug Monitoring (MATT) Annual Meeting in Milwaukee Wisconsin, April 2-4, 2025.  Their presentation topics...

Search Our Blog